Public COA audit
NAD+ · Nicotinamide Adenine Dinucleotide
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 72
- Confidence
- 85%
- Panels
- 3/7
- Purity (printed)
- 99.35%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- NAD1000-052026-2
- Identity method
- LC-MS
- Sample date
- 2026-06-01
- Issue date
- 2026-06-03
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
NAD+ Confirmed
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.35%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
Pass (both replicates)
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
99.35% purity by HPLC-UV is within normal range for research-grade NAD+. Consistent across both vials tested.
Identity confirmed by LC-MS
Mass spectrometry confirmation shows expected NAD+ molecular ion peaks. Chromatogram shows single dominant peak consistent with high purity.
Endotoxin testing performed
Both replicates passed with sensitivity ≤0.05 EU/mL per USP <85> standards.
Limited panel coverage
Heavy metals, microbial contamination, sterility, and residual solvent/water content testing not included. This is common for basic COAs but limits comprehensive quality assessment.
Batch information present
Lot number NAD1000-052026-2 clearly documented with accession number 2606010627.
Dates documented and reasonable
Received 2026-06-01, reported 2026-06-03. Two-day turnaround is reasonable for this testing scope.
Lab verification limited
Freedom Diagnostics Testing appears to be a legitimate testing service, but independent verification of accreditation status (ISO 17025, GMP, etc.) is not provided on the COA itself. Website and contact information are present.
Professional presentation
Document includes appropriate disclaimers, signature, chromatogram, mass spec data, and clear tabular results. Format is consistent with legitimate testing laboratory reports.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.